LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

NVO

74.38

-3.34%↓

ABBV

185.23

-2.89%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

NVO

74.38

-3.34%↓

ABBV

185.23

-2.89%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

NVO

74.38

-3.34%↓

ABBV

185.23

-2.89%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

NVO

74.38

-3.34%↓

ABBV

185.23

-2.89%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

NVO

74.38

-3.34%↓

ABBV

185.23

-2.89%↓

UNH

308.61

+0.35%↑

Search

Avalo Therapeutics

Fermé

4.41 -3.5

Résumé

Variation du prix de l'action

24h

Actuel

Min

4.38

Max

4.58

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+612.15% upside

Dividendes

By Dow Jones

Prochains Résultats

11 août 2025

Avalo Therapeutics Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 juin 2025, 14:44 UTC

Acquisitions, Fusions, Rachats

Justice Department Orders Safran to Sell Assets to Proceed with Buy of Collins Aerospace Business

17 juin 2025, 23:43 UTC

Market Talk

Nikkei May Fall Amid Uncertainty Over Israel-Iran Conflict -- Market Talk

17 juin 2025, 23:34 UTC

Market Talk

Gold Steady, Underpinned by Ongoing Geopolitical Tensions -- Market Talk

17 juin 2025, 23:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 juin 2025, 23:22 UTC

Market Talk

Global Energy Roundup: Market Talk

17 juin 2025, 23:22 UTC

Market Talk

Meridian Energy Set to Draw Line Under 'Annus Horribilis' -- Market Talk

17 juin 2025, 23:17 UTC

Market Talk
Acquisitions, Fusions, Rachats

Tourism Holdings Likely to Seek Higher Offer -- Market Talk

17 juin 2025, 23:05 UTC

Market Talk

Fletcher Building Could Signal Improved Shareholder Returns -- Market Talk

17 juin 2025, 23:05 UTC

Market Talk

Global Equities Roundup: Market Talk

17 juin 2025, 22:58 UTC

Market Talk

Australian Treasurer Chalmers Expected to Outline Second-Term Reform Agenda -- Market Talk

17 juin 2025, 22:55 UTC

Market Talk
Acquisitions, Fusions, Rachats

XRG Has a Good Argument for Regulatory Approval of Santos Deal -- Market Talk

17 juin 2025, 22:31 UTC

Market Talk
Acquisitions, Fusions, Rachats

Lifeway Foods CEO Not Surprised by Takeover Interest -- Market Talk

17 juin 2025, 22:14 UTC

Principaux Mouvements du Marché

Bitdeer Technologies Group Shares Fall on Note Offering

17 juin 2025, 19:49 UTC

Market Talk

Natural Gas Slow Down Gains -- Market Talk

17 juin 2025, 19:34 UTC

Market Talk

Oil Rises On Israel-Iran Conflict Uncertainty -- Market Talk

17 juin 2025, 19:10 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 juin 2025, 19:10 UTC

Market Talk

Dollar Strengthens, Treasury Yields Fall in Risk-Off Trade -- Market Talk

17 juin 2025, 18:41 UTC

Market Talk

Slowdown in US Consumer Spending Expected -- Market Talk

17 juin 2025, 18:15 UTC

Market Talk

Gold Inches Down as Profit-Taking Seen -- Market Talk

17 juin 2025, 17:44 UTC

Market Talk

Analysts Forecast Record-High Ethanol Output -- Market Talk

17 juin 2025, 16:37 UTC

Market Talk

A Buy-Canadian Policy Could Support Steel Producers -- Market Talk

17 juin 2025, 16:30 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

17 juin 2025, 16:30 UTC

Market Talk

Canada Seen Likely to Drop Digital-Services Tax -- Market Talk

17 juin 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

17 juin 2025, 16:15 UTC

Market Talk

Base Metal Prices Mixed on Risk-Off Sentiment -- Market Talk

17 juin 2025, 16:12 UTC

Market Talk

Gold Futures Fall as Safe-haven Demand Retreats -- Market Talk

17 juin 2025, 14:54 UTC

Market Talk

Oil Rises on Continued Israel-Iran Conflict -- Market Talk

17 juin 2025, 14:47 UTC

Market Talk

European Gas Climbs on Middle East Risks, EU Russian Ban Proposal -- Market Talk

17 juin 2025, 14:41 UTC

Market Talk

Natural Gas Extends Climb -- Market Talk

17 juin 2025, 14:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparaison

Variation de prix

Avalo Therapeutics prévision

Objectif de Prix

By TipRanks

612.15% hausse

Prévisions sur 12 Mois

Moyen 32.83 USD  612.15%

Haut 48 USD

Bas 15 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

6

Achat

0

Maintien

0

Vente

Éléments financiers

$